研究目的
This study evaluated the efficacy and safety of subthreshold yellow diode-laser micropulse 577 nm (SDM) in the treatment of chronic central serous chorioretinopathy (CSCR).
研究成果
The possibility of favouring reabsorption of subretinal liquid by stimulating the retinal pigment epithelium, even at the fovea, without damaging retinal tissue, opens up new frontiers for the therapy of chronic CSCR.
研究不足
The study was limited to 40 patients with non-resolving CSCR of >12 months duration. The follow-up period was from 3 to 12 months, which may not capture long-term effects.
1：Experimental Design and Method Selection:
The study involved treating 40 eyes of 40 patients with non-resolving CSCR of >12 months duration with SDM yellow laser (577 nm).
2：Sample Selection and Data Sources:
Patients were selected based on non-resolving CSCR of >12 months duration.
3：List of Experimental Equipment and Materials:
SDM yellow laser (577 nm), Best corrected visual acuity (BCVA) measurement tools, intraocular pressure (IOP) measurement tools, Amsler grid, ophthalmoscopy, fundus autofluorescence (FAF), and SD-OCT.
4：Experimental Procedures and Operational Workflow:
Patients were treated with SDM yellow laser (577 nm), followed by measurements of BCVA and IOP, Amsler grid screening, ophthalmoscopy, FAF, and SD-OCT at follow-up from 3 to 12 months.
5：Data Analysis Methods:
Statistical analysis was carried out by Student’s t-test for paired data.
独家科研数据包，助您复现前沿成果，加速创新突破
获取完整内容
